Literature DB >> 1642126

Comparison of Composite International Diagnostic Interview and clinical DSM-III-R criteria checklist diagnoses.

A Janca1, L N Robins, K K Bucholz, T S Early, J J Shayka.   

Abstract

This article describes a comparison of Composite International Diagnostic Interview (CIDI) diagnostic results and results based on clinicians' observation of CIDI assessments. Psychiatrists scored a DSM-III-R criteria checklist either while observing or after administering 20 CIDI interviews. Overall diagnostic concordance between the checklist and CIDI diagnoses was found to be good (kappa = 0.78). Good diagnostic agreement was also found for 3 groups of DSM-III-R disorders: depressive disorders (kappa = 0.84), psychoactive substance use disorders (kappa = 0.83) and anxiety phobic disorders (kappa = 0.76). These results are consistent with the results from a similar comparison between the CIDI and checklist results for ICD-10 diagnoses.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1642126     DOI: 10.1111/j.1600-0447.1992.tb03208.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  20 in total

1.  Selection of a substance use disorder diagnostic instrument by the National Drug Abuse Treatment Clinical Trials Network.

Authors:  Robert F Forman; Dace Svikis; Ivan D Montoya; Jack Blaine
Journal:  J Subst Abuse Treat       Date:  2004-07

2.  Clinical calibration of DSM-IV diagnoses in the World Mental Health (WMH) version of the World Health Organization (WHO) Composite International Diagnostic Interview (WMHCIDI).

Authors:  Ronald C Kessler; Jamie Abelson; Olga Demler; Javier I Escobar; Miriam Gibbon; Margaret E Guyer; Mary J Howes; Robert Jin; William A Vega; Ellen E Walters; Philip Wang; Alan Zaslavsky; Hui Zheng
Journal:  Int J Methods Psychiatr Res       Date:  2004       Impact factor: 4.035

3.  'Post-deployment appraisal' and the relationship with stress and psychological health in Australian veterans.

Authors:  Breanna Wright; Andrew Forbes; Helen Kelsall; David Clarke; Jill Ikin; Malcolm Sim
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-09-18       Impact factor: 4.328

4.  Major depression in Chinese Americans: the roles of stress, vulnerability, and acculturation.

Authors:  Wei-Chin Hwang; Hector F Myers
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-01-17       Impact factor: 4.328

5.  A comparison between screened NIMH and clinically interviewed control samples on neuroticism and extraversion.

Authors:  A Talati; A J Fyer; M M Weissman
Journal:  Mol Psychiatry       Date:  2007-10-16       Impact factor: 15.992

6.  A longitudinal community-based study of chronic illness, cognitive and physical function, and depression.

Authors:  Carolyn L Turvey; Susan K Schultz; Leigh Beglinger; Dawn M Klein
Journal:  Am J Geriatr Psychiatry       Date:  2009-08       Impact factor: 4.105

7.  Development and feasibility of the computerized Turkish edition of the Composite International Diagnostic Interview [DIA-X/CIDI version 2.8(TR)].

Authors:  Demet Dingoyan; Mike Mösko; Yadigar Imamoğlu; Alessa von Wolff; Jens Strehle; Hans-Ulrich Wittchen; Holger Schulz; Uwe Koch-Gromus; Andreas Heinz; Ulrike Kluge
Journal:  Int J Methods Psychiatr Res       Date:  2016-10-21       Impact factor: 4.035

8.  Child, caregiver, and family characteristics associated with emergency department use by children who remain at home after a child protective services investigation.

Authors:  Janet U Schneiderman; Michael S Hurlburt; Laurel K Leslie; Jinjin Zhang; Sarah McCue Horwitz
Journal:  Child Abuse Negl       Date:  2012-01-20

9.  Evidence for a psychotic posttraumatic stress disorder subtype based on the National Comorbidity Survey.

Authors:  Mark Shevlin; Cherie Armour; Jamie Murphy; James E Houston; Gary Adamson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-09-02       Impact factor: 4.328

10.  Social criticism moderates the relationship between anxiety and depression 10 years later.

Authors:  Kayla A Lord; Nicholas C Jacobson; Michael K Suvak; Michelle G Newman
Journal:  J Affect Disord       Date:  2020-05-21       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.